Company · CIK 1839140

# Revium Rx.

| CIK | [1839140](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001839140) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | NY |
| Listed | RVRC (OTC) |
| First annual or quarterly report | 2026-03-31 |

## Offerings

 1 registration

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-284934 | First-time registration Effective | 2025-02-14 | 2026-01-30 | 7 |

## Filings

 7

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2026-01-30 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1839140/999999999526000363/9999999995-26-000363-index.htm) Declared effective | 333-284934 | 9999999995-26-000363 |
| 2026-01-28 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1839140/000121390026008804/0001213900-26-008804-index.htm) Amendment | 333-284934 | 0001213900-26-008804 |
| 2026-01-16 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1839140/000121390026005242/0001213900-26-005242-index.htm) Amendment | 333-284934 | 0001213900-26-005242 |
| 2025-12-12 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1839140/000121390025121070/0001213900-25-121070-index.htm) Amendment | 333-284934 | 0001213900-25-121070 |
| 2025-10-03 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1839140/000121390025096094/0001213900-25-096094-index.htm) Amendment | 333-284934 | 0001213900-25-096094 |
| 2025-08-13 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1839140/000121390025075747/0001213900-25-075747-index.htm) Amendment | 333-284934 | 0001213900-25-075747 |
| 2025-02-14 | [S-1](https://www.sec.gov/Archives/edgar/data/1839140/000121390025013823/0001213900-25-013823-index.htm) Registration filed | 333-284934 | 0001213900-25-013823 |

[All filings of this company](https://equitycapital.markets/filings?cik=1839140) · [CSV](https://equitycapital.markets/filings.csv?cik=1839140)

---
Source page: https://equitycapital.markets/company/1839140 · Data: U.S. SEC EDGAR · CC BY 4.0